As awareness of nonalcoholic fatty liver disease (NAFLD) rises, it is essential to develop and implement a rigorously determined approach to identify patients who will, or will not, benefit from diagnostic evaluation.
Elliot B. Tapper, MD
Advertisement
Articles by Elliot B. Tapper, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Judge Denies Preliminary Injunction in Medicaid Work Requirements Case
2
AHRQ Grant Freeze Halts Patient Safety Research Nationwide
3
FDA Advisory Panel Votes Against Approval of Deramiocel for DMD
4
The Future of RRFL: Personalized Treatment, Novel Agents, and Moving Beyond Chemotherapy
5